Sage Therapeutics, Inc. vs. Sagely Enterprises Inc. – Trademark Opposition TTAB Proceeding 91249673

This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on July 23, 2019 and assigned serial number 91249673 by the TTAB.

Defendant:
Sagely Enterprises Inc. represented by LAWRENCE M. HADLEY of GLASER WEIL FINK HOWARD AVCHEN & SHAPIRO.
Trademark Information: SAGELY NATURALS – US Trademark Serial Number 88114685
View Trademark Status at USPTO
View Trademark Documents at USPTO

Plaintiff:
Sage Therapeutics, Inc. represented by LISA M TITTEMORE of SUNSTEIN LLP.
Trademark Information: SAGE THERAPEUTICS – US Trademark Serial Number 87366176
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
July 23, 2019 – FILED AND FEE
July 23, 2019 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
July 23, 2019 – INSTITUTED
August 30, 2019 – ANSWER
August 30, 2019 – D CHANGE OF CORRESP ADDRESS
February 11, 2020 – P CHANGE OF CORRESP ADDRESS
March 23, 2020 – P MOT FOR EXT W/ CONSENT
March 23, 2020 – EXTENSION OF TIME GRANTED
March 23, 2020 – D CHANGE OF CORRESP ADDRESS
June 02, 2020 – D MOT FOR EXT W/ CONSENT
June 02, 2020 – EXTENSION OF TIME GRANTED
August 20, 2020 – P MOT TO CONSOLIDATE
September 10, 2020 – CONSOLIDATION GRANTED; TRIAL DATES SET
January 26, 2021 – D MOT FOR EXT W/ CONSENT
January 26, 2021 – EXTENSION OF TIME GRANTED
May 21, 2021 – D MOT FOR EXT W/ CONSENT
May 21, 2021 – EXTENSION OF TIME GRANTED
July 22, 2021 – D MOT FOR EXT W/ CONSENT
July 22, 2021 – EXTENSION OF TIME GRANTED
August 06, 2021 – P MOT FOR EXT W/ CONSENT
August 10, 2021 – EXTENSION OF TIME GRANTED
September 29, 2021 – STIP FOR EXT
October 05, 2021 – EXTENSION OF TIME GRANTED
December 12, 2021 – D MOT FOR SUMMARY JUDGMENT
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *